A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

Condition:   Non-Hodgkin Lymphoma, B-cell Intervention:   Drug:  " novel "  MAB (alone or in combination) Sponsors:   Fondazione Italiana Linfomi - ETS;   Roche Pharma AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials